Compare YDES & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | YDES | ASPI |
|---|---|---|
| Founded | 2013 | 2021 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 543.0M | 637.1M |
| IPO Year | N/A | 2022 |
| Metric | YDES | ASPI |
|---|---|---|
| Price | $4.70 | $5.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 4.9K | ★ 3.7M |
| Earning Date | 05-12-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $23,849,000.00 |
| Revenue This Year | N/A | $68.41 |
| Revenue Next Year | N/A | $126.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 475.48 |
| 52 Week Low | $4.37 | $3.92 |
| 52 Week High | $25.00 | $14.49 |
| Indicator | YDES | ASPI |
|---|---|---|
| Relative Strength Index (RSI) | 36.94 | 51.31 |
| Support Level | $4.73 | $5.13 |
| Resistance Level | $5.36 | $5.88 |
| Average True Range (ATR) | 0.23 | 0.46 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 38.02 | 39.82 |
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.